Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania

BACKGROUND: The elimination of Plasmodium vivax malaria requires 8-aminoquinolines, which are contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency due to the risk of acute haemolytic anaemia. Several point-of-care devices have been developed to detect G6PD deficiency....

Descripción completa

Detalles Bibliográficos
Autores principales: Djigo, Oum Kelthoum Mamadou, Ould Khalef, Yacoub, Ould Ahmedou Salem, Mohamed Salem, Gomez, Nicolas, Basco, Leonardo, Briolant, Sébastien, Ould Mohamed Salem Boukhary, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340529/
https://www.ncbi.nlm.nih.gov/pubmed/34353361
http://dx.doi.org/10.1186/s40249-021-00889-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340529/
https://www.ncbi.nlm.nih.gov/pubmed/34353361
http://dx.doi.org/10.1186/s40249-021-00889-2

Ejemplares similares